ABSTRACT
Spinal intramedullary teratoma is a rare tumour characterised with slow progression course. Although symptoms are generally mild, long-term complaints can be observed due to the slow progression. In this report, we discuss a 29-year-old female diagnosed as mature cystic teratoma in thoracolumbar junction.
Subject(s)
Spinal Cord Neoplasms/surgery , Teratoma/surgery , Adult , Dermoid Cyst/pathology , Dermoid Cyst/surgery , Female , Humans , Laminectomy/methods , Magnetic Resonance Imaging , Spinal Cord Neoplasms/pathology , Teratoma/pathologyABSTRACT
Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism and increases the risk of premature cardiovascular diseases. In patients with FH, platelet function may be activated; however, the extent of this activation and its etiology are unclear. We aimed to evaluate the mean platelet volume (MPV), a marker of platelet activation, in patients with FH. The study group consisted of 164 patients with FH and 160 control patients. Controls were matched for age, gender, hypertension, and smoking. The MPV was significantly higher in patients with FH than in controls (9.2 ± 0.4 vs 7.9 ± 0.6 fL, respectively; P < .001). Platelet count was significantly lower among patients with FH when compared to control patients (259 ± 51 vs 272 ± 56 × 10(3)/L, respectively; P = .03). In linear regression analysis, MPV was independently associated only with total cholesterol (ß = .6, 95% confidence interval: 0.004-0.008, P < .001). We have shown that MPV was increased in patients with FH and that it was independently associated with total cholesterol level.
Subject(s)
Blood Platelets , Hyperlipoproteinemia Type II/blood , Mean Platelet Volume , Platelet Activation , Adult , Biomarkers/blood , Case-Control Studies , Chi-Square Distribution , Cholesterol/blood , Cross-Sectional Studies , Female , Humans , Hyperlipoproteinemia Type II/diagnosis , Hyperlipoproteinemia Type II/genetics , Linear Models , Male , Middle Aged , Platelet Count , Predictive Value of Tests , TurkeyABSTRACT
Enterobacter cancerogenus (formerly known as CDC Enteric Group 19; synonym with Enterobacter taylorae) has rarely been associated with human infections, and little is known regarding the epidemiology and clinical significance of this organism. We describe a community-acquired pneumonia case in a 44-year-old female due to E. cancerogenus. Identification and antimicrobial susceptibility of the microorganism was performed by the automatized VITEK 2 Compact system (bioMerieux, France). The clinical case suggests that E. cancerogenus is a potentially pathogenic microorganism in determined circumstances; underlying diseases such as bronchial asthma, empiric antibiotic treatment, wounds, diagnostic, or therapeutic instruments.
